SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Craig Sasser was appointed Chief Operating Officer effective July 1, 2026, a material C-suite promotion from Regional Vice President, with a base salary of $600,000 and 90% target bonus. Additionally, Briston Blair was promoted to Chief Strategy & Innovation Officer. These senior leadership appointments reflect significant governance and operational changes.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from AdaptHealth's June 18, 2026 annual meeting of stockholders. The filing reports the outcomes of three proposals: election of nine directors, ratification of KPMG LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. All three proposals passed with substantial majorities. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor appointment for the fiscal year.
View raw filing on EDGAR →Deep Fission completed a public offering of 2.5 million shares at $16.00 per share, generating $40 million in gross proceeds, with an additional 375,000-share greenshoe option granted to underwriters. While this is a registered public offering (not an unregistered private placement), it represents a material dilutive issuance of equity that would significantly affect a reasonable investor's assessment of ownership and capital structure, particularly for a newly public company (trading began June 18, 2026).
View raw filing on EDGAR →TechPrecision Corporation issued a press release on June 22, 2026, announcing financial results for the three months and fiscal year ended March 31, 2026. The disclosure includes consolidated revenue ($31.6M for FY2026), gross profit ($5.0M), net loss ($1.6M), and forward guidance for FY2027 (revenue $35.0M-$37.0M, EBITDA $3.0M-$4.0M). This is a standard earnings release disclosing quarterly and annual financial results, furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Terra Property Trust's June 18, 2026 annual stockholder meeting, including the election of all five director nominees and ratification of KPMG LLP as independent auditor. The filing presents detailed voting tallies for each proposal, which is the core content of shareholder vote results disclosures and material to investors assessing board composition and audit oversight.
View raw filing on EDGAR →The Company issued 2,727,272 warrants to Maxim Group LLC as part of a settlement arrangement, with the warrants exercisable into common stock at $0.6325 per share. This represents a dilutive equity issuance to a placement agent in connection with the Company's at-the-market offering program. The warrant issuance, combined with the $1,050,000 cash fee and future 3% commission on ATM proceeds, constitutes material consideration for capital-raising services and would materially dilute existing shareholders.
View raw filing on EDGAR →The filing discloses entry into a new investment advisory agreement with identical economic terms to the prior agreement, but the material event is the change in control of the Advisor (Stellus Capital Management) to Ridgepost Capital, LLC, which triggered the need for stockholder approval and renewal of the advisory agreement. While this involves a material definitive agreement, the core governance issue is the change in the investment advisor's ownership and control, which is a governance matter distinct from the specific advisory agreement mechanics.
View raw filing on EDGAR →The filing discloses entry into a new investment advisory agreement on June 22, 2026, which became effective upon the closing of an acquisition of Stellus Capital Management, LLC by Ridgepost Capital, LLC—a change of control event. While the agreement terms are identical to the prior agreement, the triggering event is a material acquisition that resulted in a change in control of the Advisor, making this a material M&A activity disclosure under Item 1.01.
View raw filing on EDGAR →This exhibit discloses ZTO Express's acquisition of the remaining 36.20% shareholding in TuXi Tech (567.5 million shares) for approximately RMB1,305.3 million through Share Purchase Agreements dated June 22, 2026. Upon completion, TuXi Tech will become a wholly-owned subsidiary. This is a material acquisition that will consolidate the company's ownership of a last-mile delivery platform and is explicitly identified as a connected transaction under Hong Kong Listing Rules Chapter 14A.
View raw filing on EDGAR →The board approved a new $50.0 million share repurchase program on June 19, 2026, which is a return of capital to shareholders. Share repurchases are classified as dividend_distribution events under the taxonomy, as they represent distributions to holders. The program is material to investors as it signals capital allocation strategy and affects share count and earnings per share.
View raw filing on EDGAR →CNH Industrial Capital LLC priced and issued $600 million in aggregate principal amount of 4.950% senior unsecured notes due 2031. This is a creation of a new direct financial obligation through debt issuance, with the net proceeds intended for working capital, general corporate purposes, and potential repayment of existing indebtedness. The transaction is material to investors as it represents a significant capital-raising event and increases the company's debt obligations.
View raw filing on EDGAR →Apogee entered into two material agreements with Paragon on June 17, 2026: an antibody discovery agreement and an exclusive worldwide license agreement for IL-31R antibodies. The license agreement grants Apogee exclusive rights to develop and commercialize IL-31R-directed antibodies with up to $23.25 million in milestone payments and low-single-digit royalties on net sales. While this is a material contract that would affect a reasonable investor's assessment of the company's pipeline and strategic partnerships, it does not fit the specific M&A, financing, or governance categories—it is a research and development partnership and licensing arrangement that is operational in nature.
View raw filing on EDGAR →Apogee entered into a definitive Agreement and Plan of Merger with AbbVie on June 18, 2026, under which AbbVie will acquire all outstanding shares of Apogee for $135.11 per share in cash, valuing the company at approximately $10.9 billion. The transaction constitutes a change of control with Apogee surviving as a wholly owned subsidiary, subject to customary closing conditions including shareholder approval and regulatory clearances, with expected closing in Q3 2026.
View raw filing on EDGAR →Holders of Apogee's non-voting common stock executed written consent adopting entry into the Merger Agreement with AbbVie, with consummation remaining subject to affirmative vote of a majority of voting common stock on the $10.9 billion acquisition.
View raw filing on EDGAR →Daniel M. Krawczyk was appointed as Chief Executive Officer and President of Rayonier Advanced Materials, effective June 22, 2026, and concurrently appointed to the Board as a Class III director. The appointment includes compensatory arrangements comprising a base salary of $1,000,000, target bonus of 100%, equity grants totaling $3,300,000, a sign-on bonus of $750,000, and an inducement LPU award of $1,750,000.
View raw filing on EDGAR →Castor Maritime announces entry into an agreement to acquire a 2023-built Kamsarmax bulk carrier vessel for $37.5 million through a wholly-owned subsidiary. The acquisition is a material capital deployment that will expand the company's fleet from 9 to 10 vessels and represents a significant asset purchase in the shipping business. The disclosure explicitly states the acquisition is expected to close by end of quarter, subject to customary closing conditions.
View raw filing on EDGAR →The filing announces the appointment of Asad Rahman as Vice President and Chief Financial Officer effective June 30, 2026, with over 25 years of finance and accounting experience from Mars and S.C. Johnson. While the section also discloses David W. Johnson's departure from the CFO role, the principal disclosed action centers on the appointment of the new CFO and his compensatory arrangement ($200,000 restricted stock award). This is material to investors as CFO changes affect financial oversight and governance.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Balchem's Annual Meeting of Shareholders held June 18, 2026. The filing reports voting outcomes on three matters: election of two Class 3 directors (David Fischer and Daniel Knutson), ratification of RSM US LLP as independent auditor, and advisory approval of named executive officer compensation. All three votes passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →The Company completed an initial public offering of 5.5 million shares at $12.50 per share, generating approximately $68.75 million in gross proceeds. This material capital-raising event significantly affects the registrant's capitalization and ownership structure.
View raw filing on EDGAR →The fund declared regular distributions per share for each class of common shares at $0.20 gross per share, with specified record and payment dates.
View raw filing on EDGAR →comScore held its Annual Meeting of Stockholders on June 16, 2026, at which stockholders voted on four proposals: election of two Class I directors (Kline and Wendling), advisory approval of named executive officer compensation, ratification of Deloitte & Touche LLP as independent auditor, and approval of an amendment to the 2018 Equity and Incentive Compensation Plan increasing available shares by 3,000,000. All proposals passed with substantial majorities.
View raw filing on EDGAR →This disclosure reports the results of the 2026 Annual Meeting of Members held on June 16, 2026, where three board managers were elected from three geographical districts with specific voting tallies provided for each candidate. The filing directly corresponds to Item 5.07 (Submission of Matters to Vote of Security Holders) and presents the outcome of shareholder/member votes on director elections, which is material to investors' understanding of corporate governance and board composition.
View raw filing on EDGAR →BrainsWay announced expansion of insurance coverage for its SWIFT Accelerated Deep TMS protocol, with eight major payers and the VA now covering the treatment, representing over 57 million covered lives. This is a material operational/commercial milestone reflecting improved market access and reimbursement for the company's core product, but does not fit the specific event categories (not earnings, M&A, litigation, or other named types). The expansion of favorable coverage policies is a significant business development that would affect investor assessment of the company's commercial prospects.
View raw filing on EDGAR →Aura Minerals' Board has approved a US$200 million share repurchase program for common shares and Brazilian Depositary Receipts, effective June 18, 2026 through June 18, 2027. The press release explicitly frames this as a capital return mechanism alongside dividends: "we maintain a clear focus on capital discipline and value creation through a balanced approach that combines robust dividend payments, opportunistic share buybacks." Share repurchases are a form of capital distribution to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The program is material as it represents a significant commitment of capital (US$200 million) and signals management confidence in cash generation and shareholder returns.
View raw filing on EDGAR →This press release discloses exploration drilling results at Alamos Gold's Island Gold District, reporting new high-grade mineralization zones and extensions across multiple targets (Island West Extension, Island West up-plunge, NS1/NS4 zones, Cline-Pick, Edwards mines). The company budgeted $43 million for 2026 exploration and reports 50,000 m of planned underground drilling. While the results describe potential sources of additional mill feed and production growth, this is an operational/exploration milestone rather than a discrete event fitting other categories. The disclosure is material as it describes significant exploration upside that could affect investor assessment of the company's growth prospects and reserve base.
View raw filing on EDGAR →OPC Energy Ltd., a Kenon subsidiary, has received tariff approval from the Israeli Electricity Authority for the Hadera power plant expansion project (850 MW combined-cycle natural gas facility) and confirmation that the project satisfies conditions for financial closing. This is a material operational and regulatory milestone for a major capital project, but does not fit the discrete event categories (M&A, debt issuance, impairment, etc.); it is a strategic business development—regulatory approval enabling project advancement—best classified as operational_other.
View raw filing on EDGAR →The 6-K discloses results of an annual general meeting of shareholders held on June 18, 2026, at which three proposals were voted on and all were approved by the requisite shareholder vote. This is a direct disclosure of shareholder vote results, matching the definition of shareholder_vote_results (Item 5.07 equivalent). The materiality is high because shareholder votes on proposals at annual meetings are material governance events affecting the registrant's direction and capital structure.
View raw filing on EDGAR →This exhibit is a supplemental letter to Tower's proxy statement seeking shareholder approval of an amended and restated compensation policy for directors and executive officers under Israeli law. The letter details proposed changes to compensation arrangements, including increases to CEO maximum annual bonus (175% to 225% of salary), CEO equity award limits (10x to 13x salary), and other executive officer compensation caps. These are material compensatory arrangements requiring shareholder approval under Section 5.02(e) of the 8-K taxonomy and Israeli corporate governance law.
View raw filing on EDGAR →RedHill Biopharma entered into a Securities Purchase Agreement on June 18, 2026, for a private placement of 8,571,429 ADSs (each representing 10,000 ordinary shares), Series A-1 and Series A-2 warrants, and pre-funded warrants at a combined purchase price of $0.70 per ADS and accompanying warrants. The offering is expected to generate approximately $6 million in gross proceeds, with potential additional proceeds of $13.4 million if warrants are fully exercised. This is a classic dilutive equity issuance to an accredited investor under Section 4(a)(2) and Regulation D, materially affecting shareholder ownership and voting rights.
View raw filing on EDGAR →RedHill Biopharma announced the closing of a private placement of 8,571,429 ADSs at $0.70 per ADS with accompanying warrants, generating $6 million upfront with up to $13.4 million in potential proceeds from warrant exercises. This is an unregistered equity issuance under Section 4(a)(2) and Regulation D, representing a dilutive capital raise typical of small- and mid-cap biopharmaceutical companies. The company explicitly notes the securities "have not been registered under the Securities Act" and references a registration rights agreement for future resale registration, confirming the private placement structure.
View raw filing on EDGAR →The filing discloses the consummation of a merger combination between the registrant and RTB Digital, Inc. on May 12, 2026, with completion of share issuance obligations under the merger agreement as of the filing date. This represents a material acquisition/change of control event, even though disclosed under Item 8.01 rather than the typical Item 1.01 or 2.01.
View raw filing on EDGAR →RTB Digital announced the launch of a real-time, AI/DeFi payment platform for professional publishers, enabling instant USDC settlement of ad revenue through Coinbase integration and a proprietary Media Liquidity Pool. This material product launch and strategic operational milestone affects the company's core business model and competitive positioning in the media technology industry.
View raw filing on EDGAR →Baker Hughes discloses an update on its pending acquisition of Chart Industries, specifically that the parties are in discussions with the European Commission regarding regulatory commitments to obtain Phase I clearance. The filing confirms the Merger Agreement entered into on July 28, 2025, and provides a status update on the regulatory approval process with an expected closing in July 2026. This is a material acquisition activity disclosure under Item 8.01 (Other Events), as it concerns the progress and regulatory status of a significant M&A transaction.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Codexis's 2026 Annual Meeting held on June 17, 2026. The filing reports final voting tallies on three proposals: election of three directors (Stephen G. Dilly, Raymond De Vré, and Rahul Singhvi), ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation. The disclosure includes vote counts (For, Against, Withheld, Abstain, Broker Non-Votes) for each proposal, certified by the Inspector of Elections.
View raw filing on EDGAR →Exhibit 99.2 discloses UMC's disposal of 3,500,832 common shares of Novatek Microelectronics Corporation through conversion of zero-coupon exchangeable bonds due 2026, generating a gain of approximately NTD 1.4 billion to retained earnings. This is a material financial transaction (41.71% of total assets, 57.09% of shareholder equity) involving a significant securities disposition, but does not fit the specific categories of debt issuance, dividend distribution, or M&A activity. Exhibit 99.1 is a routine clarification of market rumors with no substantive disclosure.
View raw filing on EDGAR →PLDT announced that VITRO Inc. (a wholly-owned subsidiary of ePLDT, itself a wholly-owned subsidiary of PLDT) has submitted a registration statement for a proposed REIT IPO. The disclosure describes a planned secondary offering of up to 1.9 billion shares expected to raise gross proceeds of up to ₱24.2 billion, representing approximately 48.95% of VITRO REIT's post-offering capital. This constitutes a material capital-raising and restructuring activity involving the creation of a new publicly-traded entity within the PLDT Group's digital infrastructure portfolio, which would materially affect investor assessment of PLDT's capital structure and strategic positioning.
View raw filing on EDGAR →The exhibit discloses two governance matters: (1) RBI approval for extension of Mr. Keki Mistry's tenure as interim Part-time Chairman for 3 months until September 18, 2026, and (2) Board approval to convene the 32nd AGM on August 5, 2026, with a proposed dividend of Rs. 13 per share subject to shareholder approval. While the dividend announcement is material, the primary focus is the interim chairman extension and AGM scheduling, which are governance events. The chairman tenure extension is material to investors as it addresses leadership continuity during an interim period, though it does not fit the specific `exec_appointment` or `exec_departure` categories since Mistry is already serving and this is merely an extension of his interim role.
View raw filing on EDGAR →The filing discloses an update on a material acquisition: Chart Industries is being acquired by Baker Hughes pursuant to a Merger Agreement entered into on July 28, 2025. The current disclosure reports progress toward closing, including ongoing regulatory discussions with the European Commission regarding Phase I review commitments. The expected closing date of July 2026 and the materiality of the transaction (a complete change of control) clearly fall within the ma_activity category.
View raw filing on EDGAR →Birkenstock closed a €900 million offering of 4.500% Senior Notes due 2033 on June 19, 2026. The filing discloses the terms of the new debt issuance, including interest rate, maturity date, ranking, covenants, and redemption provisions. The proceeds will be used to redeem existing notes, fund share repurchases, and refinance other indebtedness—all typical uses of debt issuance proceeds. This is a material creation of direct financial obligation under Item 2.03.
View raw filing on EDGAR →NOVONIX is applying for quotation of 129,334,163 ordinary fully paid shares issued on 22 June 2026 at AUD 0.16 per share as part of a placement previously announced in an Appendix 3B dated 17 June 2026. This represents a significant equity issuance that dilutes existing shareholders and raises approximately AUD 20.7 million in cash consideration, materially affecting the capital structure and ownership percentages of existing investors.
View raw filing on EDGAR →NOVONIX announced a Share Purchase Plan (SPP) offering eligible shareholders the opportunity to purchase up to A$30,000 of new fully paid ordinary shares at A$0.16 per share (a 33.3% discount to market), targeting to raise approximately A$3.0 million. This SPP follows a concurrent institutional placement that raised approximately A$20.7 million, together constituting a material dilutive equity issuance of approximately A$23.7 million.
View raw filing on EDGAR →CRH entered into a definitive Agreement and Plan of Merger on June 21, 2026, to acquire Arcosa, Inc. for $150 per share in an all-cash transaction valued at approximately $8.5 billion. The transaction includes a $5.75 billion committed bridge facility and is expected to close in Q1 2027, subject to regulatory and stockholder approvals.
View raw filing on EDGAR →EyePoint held its Annual Meeting on April 21, 2026, with stockholders voting on four proposals: election of eight directors (all passed with substantial majorities), amendment to the 2023 Long-Term Incentive Plan to increase authorized shares by 4,900,000 (approved), non-binding advisory vote on named executive officer compensation (approved), and ratification of Deloitte & Touche LLP as independent auditor (approved with 99.4% support).
View raw filing on EDGAR →MapLight disclosed topline results from the Phase 2 IRIS trial of ML-004 in autism spectrum disorder on June 22, 2026. The trial did not meet its primary endpoint for social communication deficits but showed clinically meaningful improvement in irritability in adolescents with moderate-to-severe baseline irritability, with effect sizes comparable to approved antipsychotics.
View raw filing on EDGAR →TScan announced positive initial data from Cohort C of its Phase 1 ALLOHA™ study evaluating TSC-101, including manufacturing success rates, patient enrollment, chimerism outcomes, and safety results, with confirmation that the company remains on track to initiate a Phase 3 pivotal study. This represents a material clinical development milestone for the company's lead product candidate.
View raw filing on EDGAR →Ligand entered into a Fourth Amendment to its Credit Agreement on June 22, 2026, to permit the issuance of $550 million of convertible senior notes due 2031 in a private placement to qualified institutional buyers, with an additional $82.5 million option. The amendment accommodates this material debt issuance and affects the company's capital structure.
View raw filing on EDGAR →The filing discloses that Clearwater Analytics has obtained all required regulatory approvals (including FIRB approval from the Australian Treasurer on June 19, 2026) for its previously announced merger with GT Silver BidCo, Inc., with closing expected in Q2 2026. This represents a material milestone in the completion of a merger transaction that constitutes a change of control, making it a reportable M&A activity event under Item 1.01/2.01 framework, disclosed here under Item 7.01.
View raw filing on EDGAR →Brazil Potash announced the award of a second FEED (Front-End Engineering Design) contract to WSP UK Ltd. and Redpath Deilmann for mine shafts and underground development at the Autazes Project. This completes full-project FEED coverage and is material because it represents a critical milestone toward construction debt financing with Development Finance Institutions and Export Credit Agencies. The contract value is estimated at USD 26 million (with USD 4.3 million awarded for the initial Early Works phase), and the disclosure emphasizes that shaft sinking constitutes the critical path defining the entire project construction schedule. This is a material operational/strategic milestone for the development project, not a discrete event fitting other categories.
View raw filing on EDGAR →Strategy Inc conducted an at-the-market (ATM) offering program, selling 2,714,839 shares of MSTR Stock and generating $335.5 million in net proceeds during the period, with a $21.0 billion MSTR Increase announced on March 23, 2026. ATM offerings are dilutive equity issuances that materially affect existing shareholders and represent significant capital-raising activity.
View raw filing on EDGAR →Dr. Steve Kelsey, President of Research and Development, informed the Company of his intent to retire from employment effective January 4, 2027, with a transition to senior advisor role beginning July 1, 2026.
View raw filing on EDGAR →